Anyone else retooling outreach after FDA’s draft guidance on Diversity Action Plans for late‑stage trials? We’re tweaking prescreen scripts and adding day‑1 transport plus interpreter support at screening to convert more eligible folks from 19124/19133, and I’m curious what’s moving the needle for you on getting qualified patients through to consent.
We started a 10‑min pre‑screen “consent warm‑up” call led by a neighborhood CHW (not the coordinator), which bumped show‑to‑consent about 18%; small caveat: we scripted it with legal to avoid drifting into therapeutic language — have you tried pairing it with a same‑day SMS “what to expect + time window” that can be answered on WhatsApp for 19124/19133?
We cut same‑day cancels about 20% by moving to two‑way SMS that sends a single “what to expect/what to bring” image (EN/ES) and a Lyft code that only activates the morning of screening — a cheat sheet plus the ride. Small caveat: we had to mark it as transport reimbursement in the DAP and get compliance sign‑off. @olivia_smith72 think your CHW call could trigger that SMS flow the night before?